Header

UZH-Logo

Maintenance Infos

Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol


Schindler, Christoph; Birkenfeld, Andreas L; Hanefeld, Markolf; Schatz, Ulrike; Köhler, Carsta; Grüneberg, Martin; Tschöpe, Diethelm; Blüher, Matthias; Hasslacher, Christoph; Bornstein, Stefan R (2019). Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol. Diabetes Therapy, 10(1):329-331.

Abstract

In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.

Abstract

In the original publication, the text in Table 2 stated 'Hypersensitivity to the active substance, to Ferinject, or to any of its excipients'.

Statistics

Citations

Altmetrics

Downloads

0 downloads since deposited on 01 Nov 2021
3 downloads since 12 months

Additional indexing

Item Type:Journal Article, not_refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Internal Medicine
Health Sciences > Endocrinology, Diabetes and Metabolism
Language:English
Date:February 2019
Deposited On:01 Nov 2021 10:03
Last Modified:26 Apr 2024 01:35
Publisher:Springer
ISSN:1869-6961
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1007/s13300-018-0546-6
PubMed ID:30523582
  • Content: Published Version
  • Licence: Creative Commons: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)